We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical Significance of Mean Corpuscular Volume in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.
- Authors
HAYATO WATANABE; KAZUKI KANO; ITARU HASHIMOTO; HIDEAKI SUEMATSU; TORU AOYAMA; TAKANOBU YAMADA; TAKASHI OGATA; YASUSHI RINO; TAKASHI OSHIMA
- Abstract
Background/Aim: To clarify the clinical significance of measuring the mean corpuscular volume (MCV) of red blood cells before applying neoadjuvant chemotherapy (NAC) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who will receive NAC followed by curative resection. Patients and Methods: We retrospectively investigated 169 eligible patients at the Kanagawa Cancer Center between 2011-2018. The patients were divided into high and low-MCV groups. The cutoff value of the MCV was determined by the maximum χ2 statistic value on the log-rank test and was set at 92.8 fl. Clinicopathological features and outcomes were compared between the two groups. Results: There was no significant association between the MCV and clinicopathological features. Both five-year recurrence-free survival (RFS) and overall survival (OS) in the high-MCV group were significantly poorer than those in the low-MCV group (RFS, p=0.026; OS, p=0.006). On multivariate analysis, a high-MCV was an independent predictive survival factor for RFS [hazard ratio (HR)=1.728; 95% confidence interval (CI)=1.033-2.891; p=0.037] and OS (HR=1.836; 95%CI=1.002-3.365; p=0.049). Conclusion: Measurement of the MCV before NAC may be a useful prognostic biomarker in patients with locally advanced ESCC who will receive NAC followed by curative resection.
- Subjects
ESOPHAGEAL cancer; CANCER treatment; CANCER relapse; NEOADJUVANT chemotherapy; MEDICAL centers
- Publication
In Vivo, 2022, Vol 36, Issue 5, p2371
- ISSN
0258-851X
- Publication type
Article
- DOI
10.21873/invivo.12969